Kyntra Bio
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $-1,474 | $3,738 | $1,277 | $1,076 |
Gross Profit | -1,476 | -368 | 1,740 | 942 |
EBITDA | -49,489 | -12,698 | -20,950 | -10,871 |
EBIT | -12,705 | -20,958 | -11,063 | |
Net Income | 11,974 | -15,198 | 37,943 | 148,473 |
Net Change In Cash | -1,474 | 3,738 | 1,277 | 1,076 |
Free Cash Flow | -3,991 | -13,887 | -18,328 | -1,856 |
Cash | 50,644 | 36,997 | 47,872 | 117,975 |
Basic Shares | 4,048 | 4,047 | 4,043 | 4,044 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $6,440 | $29,621 | $46,803 | $140,734 |
Gross Profit | 5,884 | 14,060 | 42,841 | 120,454 |
EBITDA | -57,546 | -142,428 | -305,197 | -282,825 |
EBIT | -58,294 | -145,120 | -315,127 | -293,429 |
Net Income | 183,452 | -47,579 | -284,232 | -293,654 |
Net Change In Cash | 6,440 | 29,621 | 46,803 | 140,734 |
Free Cash Flow | -4,812 | -138,265 | -317,540 | -184,674 |
Cash | 47,872 | 50,482 | 113,688 | 155,700 |
Basic Shares | 4,043 | 4,001 | 3,892 | 3,743 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$4.68 |
2026-03-31 | -$3.76 |
2025-12-31 | -$3.51 |
2025-09-30 | $49.61 |